Lysosome-localization and tumor-targeting of novel photosensitizers enhance the ablation of cancer

Jiahui Li,Guodong Wang,Yuhan Mai,Wei Zhang,Hailong Zhao,Yang Zhou,Liyun Chen,Yuxin Lin,Longguang Jiang,Peng Xu,Xiaolei Zhou,Cai Yuan,Mingdong Huang

DOI: https://doi.org/10.1016/j.jphotobiol.2024.113045

Abstract:Lysosomes are promising therapeutic targets for cancer therapy due to their essential function and increased vulnerability in cancer cells. Herein, we report a new category of cationic photosensitizers (compounds 1-3) containing a quaternary ammonium group. These photosensitizers exhibited selective uptake on cancer cells (about three times compared to the normal cells), lysosome-specific localization (Pearson's coefficients greater than 0.85), remarkable phototoxicity (IC50 are in the range of dozens of nM), and at the same time, favorable biosafety. Mechanically, these tumor-targeting photosensitizers function as light-controlled "bombs", inducing lysosomal membrane permeabilization (LMP), ultimately resulting in apoptosis of cancer cells. In vivo, compound 1 (a representative of these novel photosensitizers) accumulated predominantly in and visualized tumors implanted on mice. Upon exposure to near-infrared light irradiation (50 J/cm2), the compound effectively ablated the tumor at a low dose of 2 mg/kg. Our results demonstrate a novel class of photosensitizers showing potential for integrated cancer diagnosis and photodynamic treatment.